Related by context. Frequent words. (Click for all words.) 84 primary endpoints 75 primary endpoint 71 primary efficacy endpoint 70 secondary endpoints 68 secondary endpoint 66 efficacy endpoints 65 non inferiority 62 clinical endpoints 60 composite endpoint 59 clinically meaningful 59 mg BID 58 dosing regimens 58 HbA1c levels 58 pharmacodynamic 58 demonstrated statistically significant 57 achieve statistical significance 57 Secondary endpoints included 57 mg doses 57 statistical significance 57 ACTEMRA 57 INCB# [002] 57 evaluable 57 mg dose 56 telbivudine 56 evaluable patients 56 tolerability 56 DSMB 56 abatacept 56 placebo p = 56 LEVADEX 56 fasting plasma glucose 55 placebo controlled trials 55 HGS ETR1 55 dose limiting toxicities 55 pramipexole 55 free survival PFS 54 median PFS 54 peginterferon 54 ticagrelor 54 sitagliptin 54 phase IIb 54 vandetanib 54 plasma concentrations 54 pharmacokinetic profile 54 LymphoStat B 54 NGX# 54 tiotropium 54 placebo p 54 ACR# [002] 54 dosing regimen 54 Locteron 54 RG# [001] 53 creatinine clearance 53 adalimumab 53 dimebon 53 tolerability profile 53 preoperatively 53 daclizumab 53 insulin glargine 53 plus ribavirin 53 Phase 2b study 53 Zenvia 53 JANUVIA 53 statistically significant 53 mg d 53 Zerenex 53 statistically significant improvement 53 PRX # 52 ISENTRESS 52 mitoxantrone 52 aliskiren 52 placebo 52 unblinded 52 etanercept 52 valsartan 52 statistically significant reduction 52 naproxcinod 52 HbA1c 52 placebo controlled 52 Phase IIa 52 Phase IIa trial 52 CK # 52 symptom severity 52 FOLFOX 52 Welchol 52 p = #.# [002] 52 dose escalation 52 pharmacokinetic 52 reach statistical significance 52 bortezomib 52 FTY# 51 pioglitazone 51 linaclotide 51 TroVax 51 Androxal 51 Phase IIa clinical 51 multiple ascending dose 51 Phase IIb clinical 51 P = .# 51 Phase 2a 51 XGEVA